Venous Thromboembolism Therapeutics and Forecast Market
1 Introduction to Research & Analysis Reports
1.1 Venous Thromboembolism Therapeutics Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Venous Thromboembolism Therapeutics Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Venous Thromboembolism Therapeutics Overall Market Size
2.1 Global Venous Thromboembolism Therapeutics Market Size: 2022 VS 2031
2.2 Global Venous Thromboembolism Therapeutics Market Size, Prospects & Forecasts: 2019-2031
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Venous Thromboembolism Therapeutics Players in Global Market
3.2 Top Global Venous Thromboembolism Therapeutics Companies Ranked by Revenue
3.3 Global Venous Thromboembolism Therapeutics Revenue by Companies
3.4 Top 3 and Top 5 Venous Thromboembolism Therapeutics Companies in Global Market, by Revenue in 2022
3.5 Global Companies Venous Thromboembolism Therapeutics Product Type
3.6 Tier 1, Tier 2 and Tier 3 Venous Thromboembolism Therapeutics Players in Global Market
3.6.1 List of Global Tier 1 Venous Thromboembolism Therapeutics Companies
3.6.2 List of Global Tier 2 and Tier 3 Venous Thromboembolism Therapeutics Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Venous Thromboembolism Therapeutics Market Size Markets, 2022 & 2031
4.1.2 Factor Xa Inhibitors
4.1.3 Direct Thrombin Inhibitors
4.1.4 Heparin
4.1.5 Vitamin K Antagonists
4.1.6 Other
4.2 By Type - Global Venous Thromboembolism Therapeutics Revenue & Forecasts
4.2.1 By Type - Global Venous Thromboembolism Therapeutics Revenue, 2019-2024
4.2.2 By Type - Global Venous Thromboembolism Therapeutics Revenue, 2024-2031
4.2.3 By Type - Global Venous Thromboembolism Therapeutics Revenue Market Share, 2019-2031
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Venous Thromboembolism Therapeutics Market Size, 2022 & 2031
5.1.2 Hospital Pharmacies
5.1.3 Retail Pharmacies
5.1.4 Other
5.2 By Application - Global Venous Thromboembolism Therapeutics Revenue & Forecasts
5.2.1 By Application - Global Venous Thromboembolism Therapeutics Revenue, 2019-2024
5.2.2 By Application - Global Venous Thromboembolism Therapeutics Revenue, 2024-2031
5.2.3 By Application - Global Venous Thromboembolism Therapeutics Revenue Market Share, 2019-2031
6 Sights by Region
6.1 By Region - Global Venous Thromboembolism Therapeutics Market Size, 2022 & 2031
6.2 By Region - Global Venous Thromboembolism Therapeutics Revenue & Forecasts
6.2.1 By Region - Global Venous Thromboembolism Therapeutics Revenue, 2019-2024
6.2.2 By Region - Global Venous Thromboembolism Therapeutics Revenue, 2024-2031
6.2.3 By Region - Global Venous Thromboembolism Therapeutics Revenue Market Share, 2019-2031
6.3 North America
6.3.1 By Country - North America Venous Thromboembolism Therapeutics Revenue, 2019-2031
6.3.2 US Venous Thromboembolism Therapeutics Market Size, 2019-2031
6.3.3 Canada Venous Thromboembolism Therapeutics Market Size, 2019-2031
6.3.4 Mexico Venous Thromboembolism Therapeutics Market Size, 2019-2031
6.4 Europe
6.4.1 By Country - Europe Venous Thromboembolism Therapeutics Revenue, 2019-2031
6.4.2 Germany Venous Thromboembolism Therapeutics Market Size, 2019-2031
6.4.3 France Venous Thromboembolism Therapeutics Market Size, 2019-2031
6.4.4 U.K. Venous Thromboembolism Therapeutics Market Size, 2019-2031
6.4.5 Italy Venous Thromboembolism Therapeutics Market Size, 2019-2031
6.4.6 Russia Venous Thromboembolism Therapeutics Market Size, 2019-2031
6.4.7 Nordic Countries Venous Thromboembolism Therapeutics Market Size, 2019-2031
6.4.8 Benelux Venous Thromboembolism Therapeutics Market Size, 2019-2031
6.5 Asia
6.5.1 By Region - Asia Venous Thromboembolism Therapeutics Revenue, 2019-2031
6.5.2 China Venous Thromboembolism Therapeutics Market Size, 2019-2031
6.5.3 Japan Venous Thromboembolism Therapeutics Market Size, 2019-2031
6.5.4 South Korea Venous Thromboembolism Therapeutics Market Size, 2019-2031
6.5.5 Southeast Asia Venous Thromboembolism Therapeutics Market Size, 2019-2031
6.5.6 India Venous Thromboembolism Therapeutics Market Size, 2019-2031
6.6 South America
6.6.1 By Country - South America Venous Thromboembolism Therapeutics Revenue, 2019-2031
6.6.2 Brazil Venous Thromboembolism Therapeutics Market Size, 2019-2031
6.6.3 Argentina Venous Thromboembolism Therapeutics Market Size, 2019-2031
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Venous Thromboembolism Therapeutics Revenue, 2019-2031
6.7.2 Turkey Venous Thromboembolism Therapeutics Market Size, 2019-2031
6.7.3 Israel Venous Thromboembolism Therapeutics Market Size, 2019-2031
6.7.4 Saudi Arabia Venous Thromboembolism Therapeutics Market Size, 2019-2031
6.7.5 UAE Venous Thromboembolism Therapeutics Market Size, 2019-2031
7 Venous Thromboembolism Therapeutics Companies Profiles
7.1 Johnson & Johnson
7.1.1 Johnson & Johnson Company Summary
7.1.2 Johnson & Johnson Business Overview
7.1.3 Johnson & Johnson Venous Thromboembolism Therapeutics Major Product Offerings
7.1.4 Johnson & Johnson Venous Thromboembolism Therapeutics Revenue in Global Market (2019-2024)
7.1.5 Johnson & Johnson Key News & Latest Developments
7.2 Sanofi
7.2.1 Sanofi Company Summary
7.2.2 Sanofi Business Overview
7.2.3 Sanofi Venous Thromboembolism Therapeutics Major Product Offerings
7.2.4 Sanofi Venous Thromboembolism Therapeutics Revenue in Global Market (2019-2024)
7.2.5 Sanofi Key News & Latest Developments
7.3 Boehringer Ingelheim
7.3.1 Boehringer Ingelheim Company Summary
7.3.2 Boehringer Ingelheim Business Overview
7.3.3 Boehringer Ingelheim Venous Thromboembolism Therapeutics Major Product Offerings
7.3.4 Boehringer Ingelheim Venous Thromboembolism Therapeutics Revenue in Global Market (2019-2024)
7.3.5 Boehringer Ingelheim Key News & Latest Developments
7.4 Daiichi Sankyo
7.4.1 Daiichi Sankyo Company Summary
7.4.2 Daiichi Sankyo Business Overview
7.4.3 Daiichi Sankyo Venous Thromboembolism Therapeutics Major Product Offerings
7.4.4 Daiichi Sankyo Venous Thromboembolism Therapeutics Revenue in Global Market (2019-2024)
7.4.5 Daiichi Sankyo Key News & Latest Developments
7.5 Bristol-Myers Squibb (BMS)
7.5.1 Bristol-Myers Squibb (BMS) Company Summary
7.5.2 Bristol-Myers Squibb (BMS) Business Overview
7.5.3 Bristol-Myers Squibb (BMS) Venous Thromboembolism Therapeutics Major Product Offerings
7.5.4 Bristol-Myers Squibb (BMS) Venous Thromboembolism Therapeutics Revenue in Global Market (2019-2024)
7.5.5 Bristol-Myers Squibb (BMS) Key News & Latest Developments
7.6 Bayer HealthCare
7.6.1 Bayer HealthCare Company Summary
7.6.2 Bayer HealthCare Business Overview
7.6.3 Bayer HealthCare Venous Thromboembolism Therapeutics Major Product Offerings
7.6.4 Bayer HealthCare Venous Thromboembolism Therapeutics Revenue in Global Market (2019-2024)
7.6.5 Bayer HealthCare Key News & Latest Developments
7.7 Pfizer
7.7.1 Pfizer Company Summary
7.7.2 Pfizer Business Overview
7.7.3 Pfizer Venous Thromboembolism Therapeutics Major Product Offerings
7.7.4 Pfizer Venous Thromboembolism Therapeutics Revenue in Global Market (2019-2024)
7.7.5 Pfizer Key News & Latest Developments
7.8 Leo Pharma
7.8.1 Leo Pharma Company Summary
7.8.2 Leo Pharma Business Overview
7.8.3 Leo Pharma Venous Thromboembolism Therapeutics Major Product Offerings
7.8.4 Leo Pharma Venous Thromboembolism Therapeutics Revenue in Global Market (2019-2024)
7.8.5 Leo Pharma Key News & Latest Developments
7.9 Portola Pharmaceuticals
7.9.1 Portola Pharmaceuticals Company Summary
7.9.2 Portola Pharmaceuticals Business Overview
7.9.3 Portola Pharmaceuticals Venous Thromboembolism Therapeutics Major Product Offerings
7.9.4 Portola Pharmaceuticals Venous Thromboembolism Therapeutics Revenue in Global Market (2019-2024)
7.9.5 Portola Pharmaceuticals Key News & Latest Developments
7.10 ThromboGenics
7.10.1 ThromboGenics Company Summary
7.10.2 ThromboGenics Business Overview
7.10.3 ThromboGenics Venous Thromboembolism Therapeutics Major Product Offerings
7.10.4 ThromboGenics Venous Thromboembolism Therapeutics Revenue in Global Market (2019-2024)
7.10.5 ThromboGenics Key News & Latest Developments
7.11 Ionis Pharmaceuticals
7.11.1 Ionis Pharmaceuticals Company Summary
7.11.2 Ionis Pharmaceuticals Business Overview
7.11.3 Ionis Pharmaceuticals Venous Thromboembolism Therapeutics Major Product Offerings
7.11.4 Ionis Pharmaceuticals Venous Thromboembolism Therapeutics Revenue in Global Market (2019-2024)
7.11.5 Ionis Pharmaceuticals Key News & Latest Developments
7.12 GlycoMimetics
7.12.1 GlycoMimetics Company Summary
7.12.2 GlycoMimetics Business Overview
7.12.3 GlycoMimetics Venous Thromboembolism Therapeutics Major Product Offerings
7.12.4 GlycoMimetics Venous Thromboembolism Therapeutics Revenue in Global Market (2019-2024)
7.12.5 GlycoMimetics Key News & Latest Developments
7.13 BioInvent International
7.13.1 BioInvent International Company Summary
7.13.2 BioInvent International Business Overview
7.13.3 BioInvent International Venous Thromboembolism Therapeutics Major Product Offerings
7.13.4 BioInvent International Venous Thromboembolism Therapeutics Revenue in Global Market (2019-2024)
7.13.5 BioInvent International Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
List of Tables
Table 1. Venous Thromboembolism Therapeutics Market Opportunities & Trends in Global Market
Table 2. Venous Thromboembolism Therapeutics Market Drivers in Global Market
Table 3. Venous Thromboembolism Therapeutics Market Restraints in Global Market
Table 4. Key Players of Venous Thromboembolism Therapeutics in Global Market
Table 5. Top Venous Thromboembolism Therapeutics Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Venous Thromboembolism Therapeutics Revenue by Companies, (US$, Mn), 2019-2024
Table 7. Global Venous Thromboembolism Therapeutics Revenue Share by Companies, 2019-2024
Table 8. Global Companies Venous Thromboembolism Therapeutics Product Type
Table 9. List of Global Tier 1 Venous Thromboembolism Therapeutics Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Venous Thromboembolism Therapeutics Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Venous Thromboembolism Therapeutics Revenue, (US$, Mn), 2022 & 2031
Table 12. By Type - Venous Thromboembolism Therapeutics Revenue in Global (US$, Mn), 2019-2024
Table 13. By Type - Venous Thromboembolism Therapeutics Revenue in Global (US$, Mn), 2024-2031
Table 14. By Application ? Global Venous Thromboembolism Therapeutics Revenue, (US$, Mn), 2022 & 2031
Table 15. By Application - Venous Thromboembolism Therapeutics Revenue in Global (US$, Mn), 2019-2024
Table 16. By Application - Venous Thromboembolism Therapeutics Revenue in Global (US$, Mn), 2024-2031
Table 17. By Region ? Global Venous Thromboembolism Therapeutics Revenue, (US$, Mn), 2022 & 2031
Table 18. By Region - Global Venous Thromboembolism Therapeutics Revenue (US$, Mn), 2019-2024
Table 19. By Region - Global Venous Thromboembolism Therapeutics Revenue (US$, Mn), 2024-2031
Table 20. By Country - North America Venous Thromboembolism Therapeutics Revenue, (US$, Mn), 2019-2024
Table 21. By Country - North America Venous Thromboembolism Therapeutics Revenue, (US$, Mn), 2024-2031
Table 22. By Country - Europe Venous Thromboembolism Therapeutics Revenue, (US$, Mn), 2019-2024
Table 23. By Country - Europe Venous Thromboembolism Therapeutics Revenue, (US$, Mn), 2024-2031
Table 24. By Region - Asia Venous Thromboembolism Therapeutics Revenue, (US$, Mn), 2019-2024
Table 25. By Region - Asia Venous Thromboembolism Therapeutics Revenue, (US$, Mn), 2024-2031
Table 26. By Country - South America Venous Thromboembolism Therapeutics Revenue, (US$, Mn), 2019-2024
Table 27. By Country - South America Venous Thromboembolism Therapeutics Revenue, (US$, Mn), 2024-2031
Table 28. By Country - Middle East & Africa Venous Thromboembolism Therapeutics Revenue, (US$, Mn), 2019-2024
Table 29. By Country - Middle East & Africa Venous Thromboembolism Therapeutics Revenue, (US$, Mn), 2024-2031
Table 30. Johnson & Johnson Company Summary
Table 31. Johnson & Johnson Venous Thromboembolism Therapeutics Product Offerings
Table 32. Johnson & Johnson Venous Thromboembolism Therapeutics Revenue (US$, Mn) & (2019-2024)
Table 33. Johnson & Johnson Key News & Latest Developments
Table 34. Sanofi Company Summary
Table 35. Sanofi Venous Thromboembolism Therapeutics Product Offerings
Table 36. Sanofi Venous Thromboembolism Therapeutics Revenue (US$, Mn) & (2019-2024)
Table 37. Sanofi Key News & Latest Developments
Table 38. Boehringer Ingelheim Company Summary
Table 39. Boehringer Ingelheim Venous Thromboembolism Therapeutics Product Offerings
Table 40. Boehringer Ingelheim Venous Thromboembolism Therapeutics Revenue (US$, Mn) & (2019-2024)
Table 41. Boehringer Ingelheim Key News & Latest Developments
Table 42. Daiichi Sankyo Company Summary
Table 43. Daiichi Sankyo Venous Thromboembolism Therapeutics Product Offerings
Table 44. Daiichi Sankyo Venous Thromboembolism Therapeutics Revenue (US$, Mn) & (2019-2024)
Table 45. Daiichi Sankyo Key News & Latest Developments
Table 46. Bristol-Myers Squibb (BMS) Company Summary
Table 47. Bristol-Myers Squibb (BMS) Venous Thromboembolism Therapeutics Product Offerings
Table 48. Bristol-Myers Squibb (BMS) Venous Thromboembolism Therapeutics Revenue (US$, Mn) & (2019-2024)
Table 49. Bristol-Myers Squibb (BMS) Key News & Latest Developments
Table 50. Bayer HealthCare Company Summary
Table 51. Bayer HealthCare Venous Thromboembolism Therapeutics Product Offerings
Table 52. Bayer HealthCare Venous Thromboembolism Therapeutics Revenue (US$, Mn) & (2019-2024)
Table 53. Bayer HealthCare Key News & Latest Developments
Table 54. Pfizer Company Summary
Table 55. Pfizer Venous Thromboembolism Therapeutics Product Offerings
Table 56. Pfizer Venous Thromboembolism Therapeutics Revenue (US$, Mn) & (2019-2024)
Table 57. Pfizer Key News & Latest Developments
Table 58. Leo Pharma Company Summary
Table 59. Leo Pharma Venous Thromboembolism Therapeutics Product Offerings
Table 60. Leo Pharma Venous Thromboembolism Therapeutics Revenue (US$, Mn) & (2019-2024)
Table 61. Leo Pharma Key News & Latest Developments
Table 62. Portola Pharmaceuticals Company Summary
Table 63. Portola Pharmaceuticals Venous Thromboembolism Therapeutics Product Offerings
Table 64. Portola Pharmaceuticals Venous Thromboembolism Therapeutics Revenue (US$, Mn) & (2019-2024)
Table 65. Portola Pharmaceuticals Key News & Latest Developments
Table 66. ThromboGenics Company Summary
Table 67. ThromboGenics Venous Thromboembolism Therapeutics Product Offerings
Table 68. ThromboGenics Venous Thromboembolism Therapeutics Revenue (US$, Mn) & (2019-2024)
Table 69. ThromboGenics Key News & Latest Developments
Table 70. Ionis Pharmaceuticals Company Summary
Table 71. Ionis Pharmaceuticals Venous Thromboembolism Therapeutics Product Offerings
Table 72. Ionis Pharmaceuticals Venous Thromboembolism Therapeutics Revenue (US$, Mn) & (2019-2024)
Table 73. Ionis Pharmaceuticals Key News & Latest Developments
Table 74. GlycoMimetics Company Summary
Table 75. GlycoMimetics Venous Thromboembolism Therapeutics Product Offerings
Table 76. GlycoMimetics Venous Thromboembolism Therapeutics Revenue (US$, Mn) & (2019-2024)
Table 77. GlycoMimetics Key News & Latest Developments
Table 78. BioInvent International Company Summary
Table 79. BioInvent International Venous Thromboembolism Therapeutics Product Offerings
Table 80. BioInvent International Venous Thromboembolism Therapeutics Revenue (US$, Mn) & (2019-2024)
Table 81. BioInvent International Key News & Latest Developments
List of Figures
Figure 1. Venous Thromboembolism Therapeutics Segment by Type in 2022
Figure 2. Venous Thromboembolism Therapeutics Segment by Application in 2022
Figure 3. Global Venous Thromboembolism Therapeutics Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Venous Thromboembolism Therapeutics Market Size: 2022 VS 2031 (US$, Mn)
Figure 6. Global Venous Thromboembolism Therapeutics Revenue, 2019-2031 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Venous Thromboembolism Therapeutics Revenue in 2022
Figure 8. By Type - Global Venous Thromboembolism Therapeutics Revenue Market Share, 2019-2031
Figure 9. By Application - Global Venous Thromboembolism Therapeutics Revenue Market Share, 2019-2031
Figure 10. By Type - Global Venous Thromboembolism Therapeutics Revenue, (US$, Mn), 2022 & 2031
Figure 11. By Type - Global Venous Thromboembolism Therapeutics Revenue Market Share, 2019-2031
Figure 12. By Application - Global Venous Thromboembolism Therapeutics Revenue, (US$, Mn), 2022 & 2031
Figure 13. By Application - Global Venous Thromboembolism Therapeutics Revenue Market Share, 2019-2031
Figure 14. By Region - Global Venous Thromboembolism Therapeutics Revenue Market Share, 2019-2031
Figure 15. By Country - North America Venous Thromboembolism Therapeutics Revenue Market Share, 2019-2031
Figure 16. US Venous Thromboembolism Therapeutics Revenue, (US$, Mn), 2019-2031
Figure 17. Canada Venous Thromboembolism Therapeutics Revenue, (US$, Mn), 2019-2031
Figure 18. Mexico Venous Thromboembolism Therapeutics Revenue, (US$, Mn), 2019-2031
Figure 19. By Country - Europe Venous Thromboembolism Therapeutics Revenue Market Share, 2019-2031
Figure 20. Germany Venous Thromboembolism Therapeutics Revenue, (US$, Mn), 2019-2031
Figure 21. France Venous Thromboembolism Therapeutics Revenue, (US$, Mn), 2019-2031
Figure 22. U.K. Venous Thromboembolism Therapeutics Revenue, (US$, Mn), 2019-2031
Figure 23. Italy Venous Thromboembolism Therapeutics Revenue, (US$, Mn), 2019-2031
Figure 24. Russia Venous Thromboembolism Therapeutics Revenue, (US$, Mn), 2019-2031
Figure 25. Nordic Countries Venous Thromboembolism Therapeutics Revenue, (US$, Mn), 2019-2031
Figure 26. Benelux Venous Thromboembolism Therapeutics Revenue, (US$, Mn), 2019-2031
Figure 27. By Region - Asia Venous Thromboembolism Therapeutics Revenue Market Share, 2019-2031
Figure 28. China Venous Thromboembolism Therapeutics Revenue, (US$, Mn), 2019-2031
Figure 29. Japan Venous Thromboembolism Therapeutics Revenue, (US$, Mn), 2019-2031
Figure 30. South Korea Venous Thromboembolism Therapeutics Revenue, (US$, Mn), 2019-2031
Figure 31. Southeast Asia Venous Thromboembolism Therapeutics Revenue, (US$, Mn), 2019-2031
Figure 32. India Venous Thromboembolism Therapeutics Revenue, (US$, Mn), 2019-2031
Figure 33. By Country - South America Venous Thromboembolism Therapeutics Revenue Market Share, 2019-2031
Figure 34. Brazil Venous Thromboembolism Therapeutics Revenue, (US$, Mn), 2019-2031
Figure 35. Argentina Venous Thromboembolism Therapeutics Revenue, (US$, Mn), 2019-2031
Figure 36. By Country - Middle East & Africa Venous Thromboembolism Therapeutics Revenue Market Share, 2019-2031
Figure 37. Turkey Venous Thromboembolism Therapeutics Revenue, (US$, Mn), 2019-2031
Figure 38. Israel Venous Thromboembolism Therapeutics Revenue, (US$, Mn), 2019-2031
Figure 39. Saudi Arabia Venous Thromboembolism Therapeutics Revenue, (US$, Mn), 2019-2031
Figure 40. UAE Venous Thromboembolism Therapeutics Revenue, (US$, Mn), 2019-2031
Figure 41. Johnson & Johnson Venous Thromboembolism Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 42. Sanofi Venous Thromboembolism Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 43. Boehringer Ingelheim Venous Thromboembolism Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 44. Daiichi Sankyo Venous Thromboembolism Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 45. Bristol-Myers Squibb (BMS) Venous Thromboembolism Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 46. Bayer HealthCare Venous Thromboembolism Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 47. Pfizer Venous Thromboembolism Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 48. Leo Pharma Venous Thromboembolism Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 49. Portola Pharmaceuticals Venous Thromboembolism Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 50. ThromboGenics Venous Thromboembolism Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 51. Ionis Pharmaceuticals Venous Thromboembolism Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 52. GlycoMimetics Venous Thromboembolism Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 53. BioInvent International Venous Thromboembolism Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Industry Market Size
